Novel Therapies to Address Unmet Needs in ITP
Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current corticosteroid-based ITP therapies are able to improve platelet counts, up to 70% of subjects with an ITP diagnosis do not achieve a sustained clinical respo...
Saved in:
Main Authors: | María Eva Mingot-Castellano (Author), José María Bastida (Author), Gonzalo Caballero-Navarro (Author), Laura Entrena Ureña (Author), Tomás José González-López (Author), José Ramón González-Porras (Author), Nora Butta (Author), Mariana Canaro (Author), Reyes Jiménez-Bárcenas (Author), María del Carmen Gómez del Castillo Solano (Author), Blanca Sánchez-González (Author), Cristina Pascual-Izquierdo (Author), on behalf of the GEPTI (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018
by: Emilio Monteagudo, et al.
Published: (2019) -
Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients
by: Marco Dionisi, et al.
Published: (2021) -
Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease
by: Onisâi Minodora, et al.
Published: (2019) -
Problems With Section Two ITP TOEFL Test
by: Rizki Ananda
Published: (2016) -
Intracranial haemorrhage in Childhood ITP: An unfortunate twist of fate
by: Dr. Richa, et al.
Published: (2016)